{"id":"CHEMBL106258","canonicalSmiles":"NC1=NCC(c2ccccc2)O1","inchiKey":"SYAKTDIEAPMBAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Apiquel"],"synonyms":["Aminorex","Aminoxaphen","MCN-742","NSC-66952"],"crossReferences":{"Wikipedia":["Aminorex"],"drugbank":["DB01490"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1089636","canonicalSmiles":"CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]3C[C@@]4(O)[C@@H](OC(=O)c5ccccc5)[C@H]5[C@](C)(C(=O)[C@H](OC(C)=O)C(=C3C)C4(C)C)[C@@H](O)C[C@H]3OC[C@]35OC(C)=O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]3C[C@@]4(O)[C@@H](OC(=O)c5ccccc5)[C@H]5[C@](C)(C(=O)[C@H](OC(C)=O)C(=C3C)C4(C)C)[C@@H](O)C[C@H]3OC[C@]35OC(C)=O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C","inchiKey":"GBVKRUOMSUTVPW-AHNVSIPUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANG1005","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANG-1005","ANG1005","Ang1005","Paclitaxel trevatide"],"linkedTargets":{"rows":["ENSG00000123384","ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":16},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0100342","EFO_0003833","EFO_0000519"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1092665","canonicalSmiles":"COCCOCCOc1ccc(C2=N[C@@](C)(C(=O)O)CS2)c(O)c1","inchiKey":"YASYAEVZKXPYIZ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SP-420","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SP-420","Sp-420"],"childChemblIds":["CHEMBL1091900"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1094785","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1","inchiKey":"IHOXNOQMRZISPV-YJYMSZOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMOTEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHF-4226","Carmoterol","Chf 4226","Quinoterol","TA-2005"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1117","canonicalSmiles":"CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O","inchiKey":"XDXDZDZNSLXDNA-TZNDIEGXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IDARUBICIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Idamycin","Idarubicin"],"crossReferences":{"DailyMed":["idarubicin%20hydrochloride"],"PubChem":["124891657","50106402","50106403","50106404","90340569"],"Wikipedia":["Idarubicin"],"drugbank":["DB01177"],"chEBI":["42068"]},"childChemblIds":["CHEMBL1200976"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_1001257","MONDO_0000873","EFO_0003812","MONDO_0044887","EFO_1000131","EFO_1001945","EFO_0005952","MONDO_0003541","EFO_0000565","EFO_0004251","MONDO_0001475","EFO_0000339","EFO_0000182","EFO_0000330","MONDO_0020743","EFO_0000198","EFO_0003802","EFO_0000221","EFO_0000616","EFO_1001779","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_0000223","EFO_1001946","EFO_1001968","EFO_0000224","EFO_0003025","EFO_1001934","MONDO_0002691","EFO_0002428","EFO_0000574","EFO_0001378","EFO_0000218","MONDO_0004643","EFO_0003027","EFO_0003811"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for acute myeloid leukemia and neoplasm and has 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200507","canonicalSmiles":"CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"NBQNWMBBSKPBAY-UHFFFAOYSA-N","drugType":"Unknown","blackBoxWarning":true,"name":"IODIXANOL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Visipaque","Visipaque 270","Visipaque 320"],"synonyms":["2-5410-3A","2-541O-3A","Iodixanol","NSC-760069"],"crossReferences":{"PubChem":["144204262","170464924"],"Wikipedia":["Iodixanol"],"drugbank":["DB01249"],"chEBI":["31705"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200638","canonicalSmiles":"CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SRGKFVAASLQVBO-DASCVMRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXBROMPHENIRAMINE MALEATE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201287","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disomer"],"synonyms":["Brompheniramine d-form maleate","Dexbrompheniramine fumarate","Dexbrompheniramine maleate"],"crossReferences":{"PubChem":["144205553","170465028","49681545","50105972"],"chEBI":["59273"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003956"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1963 and is indicated for seasonal allergic rhinitis."}
{"id":"CHEMBL1200640","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS FUMARATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Feostat","Fersaday","Fersamal","Galfer","Meterfer","Toleron"],"synonyms":["Cpiron","Erco-fer","Ercoferro","Ferrofume","Ferrosi fumaras","Ferrous fumarate","Heferol","Hemoton","Ircon","Iron (as ferrous fumarate)","Iron (as fumarate)","Iron fumarate","Orgasal","Palafer","Tolferain","Tolifer"],"crossReferences":{"DrugCentral":["4261"],"Wikipedia":["Iron(II)_fumarate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1200832","canonicalSmiles":"CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12.Cl","inchiKey":"BWMISRWJRUSYEX-SZKNIZGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERBINAFINE HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL822","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athlete's foot","Lamisil","Lamisil at","Lamisil once","Terbinafine hydrochloride"],"synonyms":["Bramazil","Bramizil","Muzonal","NSC-759113","Terbina","Terbinafine (as hydrochloride)","Terbinafine HCl","Terbinafine hcl","Terbinafine hydrochloride","Terbine"],"crossReferences":{"DailyMed":["terbinafine%20hydrochloride"],"PubChem":["49648782"],"chEBI":["77614"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL1200854","canonicalSmiles":"CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"VIQCGTZFEYDQMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUPHENAZINE DECANOATE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decazate","Fluphenazine decanoate","Modecate","Modecate conc","Prolixin decanoate"],"synonyms":["Dapotum d","Fluphenazine decanoate","Fluphenazini decanoas","Lyogen","Moditen depot","NSC-169510","QD-10733","SQ-10733"],"crossReferences":{"DailyMed":["fluphenazine%20decanoate"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000677","EFO_0000676","EFO_0005407"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for mental or behavioural disorder and psychosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200969","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1cc(C(F)(F)F)ccc1C(F)(F)F","inchiKey":"JWJOTENAMICLJG-QWBYCMEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUTASTERIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avodart","Dutasteride"],"synonyms":["Avolve","Duastride","Dutasteride","GG-745","GI 198745","GI-198745","NSC-740477","NSC-759880"],"crossReferences":{"DailyMed":["dutasteride"],"PubChem":["144205752"],"Wikipedia":["Dutasteride"],"drugbank":["DB01126"],"chEBI":["521033"]},"linkedTargets":{"rows":["ENSG00000277893","ENSG00000128039","ENSG00000145545"],"count":3},"linkedDiseases":{"rows":["EFO_0000284","Orphanet_481","MONDO_0008315","EFO_0001663","MONDO_0002046","GO_0007568","MONDO_0002146","MONDO_0100096","Orphanet_79364","EFO_0000673","EFO_0003830","MONDO_0004976","MONDO_0007079","EFO_0004191"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL1200986","canonicalSmiles":"CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"GUTXTARXLVFHDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HALOPERIDOL DECANOATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Haldol","Haldol Dec","Haloperidol decanoate"],"synonyms":["Halomonth","Haloperidol decanoate","R-13,672","R-13672"],"crossReferences":{"DailyMed":["haloperidol%20decanoate"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004216","EFO_0004895","EFO_0000677","EFO_0005407","EFO_0009267","EFO_0005411"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 5 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201019","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=CCS[C@H]12)c1csc(N)n1.[Na+]","inchiKey":"ADLFUPFRVXCDMO-LIGXYSTNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIZOXIME SODIUM","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL528","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefizox","Epocelin"],"synonyms":["Ceftizoxime sodium","Ceftizoxime sodium salt","FK 749","FK-749","FR 13749","FR-13749","SK&F 88373-Z","SK&F-88373-Z","Sodium ceftizoxime"],"crossReferences":{"PubChem":["144206017"],"chEBI":["3512"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and has 1 investigational indication."}
{"id":"CHEMBL1201093","canonicalSmiles":"COC(=O)CCC(=O)CN.Cl","inchiKey":"UJYSYPVQHFNBML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL AMINOLEVULINATE HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1096562","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metvixia"],"synonyms":["Methyl aminolevulinate hcl","Methyl aminolevulinate hydrochloride","P-1202"],"crossReferences":{"PubChem":["144204400","855626"],"chEBI":["60641"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for glioma and has 2 investigational indications."}
{"id":"CHEMBL1201101","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1","inchiKey":"HPFVBGJFAYZEBE-ZLQWOROUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESTOSTERONE CYPIONATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Andro-Cyp","Depandro","Depo-testosterone","Depotest","Testosterone","Testosterone cypionate"],"synonyms":["Depo-Testadiol","NSC-9157","Testosterone 17.beta.-cyclopentanepropionate","Testosterone cipionate","Testosterone cyclopentylpropionate","Testosterone cypionate","Testosterone cypionate ciii"],"crossReferences":{"DailyMed":["testosterone%20cypionate"],"drugbank":["DB13943"],"chEBI":["9463"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001078","EFO_1000783","MONDO_0002146","EFO_0004714","EFO_1001006","EFO_0000673","EFO_0000196","MONDO_0008315"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL1201266","canonicalSmiles":"N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1","inchiKey":"RVGLGHVJXCETIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODOXAMIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lodoxamide"],"crossReferences":{"DailyMed":["lodoxamide%20tromethamine"],"PubChem":["170465346"],"Wikipedia":["Lodoxamide"],"drugbank":["DB06794"]},"childChemblIds":["CHEMBL1201175","CHEMBL3989725"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and is indicated for eye allergy."}
{"id":"CHEMBL1201527","drugType":"Unknown","blackBoxWarning":false,"name":"TECHNETIUM TC 99M RED BLOOD CELLS","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rbc-scan","Ultratag","Ultratag rbc"],"synonyms":["Technetium tc 99m red blood cells","Technetium tc-99m red blood cell","Technetium tc-99m red blood cell kit"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1201616","drugType":"Protein","blackBoxWarning":false,"name":"SECRETIN SYNTHETIC PORCINE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Secreflo"],"synonyms":["Porcine secretin acetate salt","RG-1068","Secretin (swine), acetate (salt)","Secretin porcine pentaacetate","Secretin synthetic porcine"],"linkedTargets":{"rows":["ENSG00000080293"],"count":1},"linkedDiseases":{"rows":["EFO_0003758"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2002 and has 1 investigational indication."}
{"id":"CHEMBL1201647","drugType":"Unknown","blackBoxWarning":false,"name":"SUGAR, INVERT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C0171","Corn invert sugar","Corn invert sugar syrup","Insubeta","Invert sugar","Invertose","Lipoderma aa","Maize invert sugar","Nulomoline","Saccharide hydrolysate","Sugar, invert","Travert","Unimoist u-125"],"crossReferences":{"Wikipedia":["Inverted_sugar_syrup"]},"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for varicose veins."}
{"id":"CHEMBL1201740","canonicalSmiles":"Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O","inchiKey":"YCBPQSYLYYBPDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NILOTINIB HYDROCHLORIDE MONOHYDRATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL255863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tasigna"],"synonyms":["Nilotinib (as hydrochloride)","Nilotinib Hydrochloride Monohydrate","Nilotinib hydrochloride","Nilotinib hydrochloride hydrate","Nilotinib hydrochloride monohydrate"],"crossReferences":{"DailyMed":["nilotinib%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","MONDO_0005180","MONDO_0007254","EFO_0000717"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for chronic myelogenous leukemia and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1208572","canonicalSmiles":"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C","inchiKey":"KQXDHUJYNAXLNZ-XQSDOZFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALINOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E716","Procoxacin","Salinomycin"],"crossReferences":{"Wikipedia":["Salinomycin"],"drugbank":["DB11544"],"chEBI":["80025"]},"childChemblIds":["CHEMBL1077120","CHEMBL1728431"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230135","canonicalSmiles":"Cc1cc(C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](/C=C/C(=O)OCc2ccccc2)C[C@@H]2CCNC2=O)C(C)C)no1","inchiKey":"IDBWWEGDLCFCTD-VNEMRZQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230135","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04595"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230969","canonicalSmiles":"CN(C)C1=N[C@H]2[C@@H](O1)[C@H](CO)[C@@H](O)[C@@H]2O","inchiKey":"MKJAYSJDHSEFRI-PVFLNQBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOSAMIZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allosamizoline"],"crossReferences":{"drugbank":["DB04404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231458","canonicalSmiles":"O=C(O)CCCCCCCCCCCBr","inchiKey":"YYKBWYBUCFHYPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231458","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210065"],"drugbank":["DB02405"],"chEBI":["49519"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123292","canonicalSmiles":"C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1","inchiKey":"YPHMISFOHDHNIV-FSZOTQKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOHEXIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cicloheximide","Cycloheximide","GNF-Pf-5118","NSC-171","NSC-185","TCMDC-125838","U-4527"],"crossReferences":{"PubChem":["103076162","124883128","124883129","144207129","144208356","144213954","170466349","17389082","17389083","26752000","50104677","56463698","67121"],"Wikipedia":["Cycloheximide"],"chEBI":["27641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234268","canonicalSmiles":"CSCC[C@@H](N)C(=O)O","inchiKey":"FFEARJCKVFRZRR-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234268","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756692"],"drugbank":["DB02893"],"chEBI":["16867"]},"childChemblIds":["CHEMBL4228668"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234521","canonicalSmiles":"C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O","inchiKey":"UURAUHCOJAIIRQ-QGLSALSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAMULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Denagard"],"synonyms":["SO 14055","SQ 14055","SQ-14055","Tiamulin"],"crossReferences":{"drugbank":["DB11468"],"chEBI":["44137"]},"childChemblIds":["CHEMBL2146129"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236107","canonicalSmiles":"Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1","inchiKey":"BCZUAADEACICHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SGX-523","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGX-523","SGX523","Sgx-523"],"crossReferences":{"PubChem":["137276007","174006581"],"drugbank":["DB06314"],"chEBI":["90624"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1236433","canonicalSmiles":"O=C(CC(=O)C(F)(F)F)c1cccs1","inchiKey":"TXBBUSUXYMIVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236433","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04795"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236670","canonicalSmiles":"CC1=C\\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\\C=C\\1","inchiKey":"DAIKHDNSXMZDCU-FQTGFAPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIRGINIAMYCIN FACTOR M1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antibiotic pa 114a","Antibiotic pa 114a1","Mikamycin a","NSC-244426","NSC-87432","Ostreogrycin a","PA-114A","Pristinamycin iia","RP-12536","Staphylomycin m1","Streptogramin a","Vernamycin a","Virginiamycin factor m1","Virginiamycin m1"],"crossReferences":{"drugbank":["DB01669"],"chEBI":["9997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1328913","canonicalSmiles":"CN(C)CCCN1c2ccccc2C(C)(C)c2ccccc21","inchiKey":"RYQOGSFEJBUZBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETACRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimetacrine","Dimethacrin","Dimethacrine","NSC-100297"],"crossReferences":{"PubChem":["144203594","403738","4253491"],"drugbank":["DB08996"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL146755","canonicalSmiles":"O=C(O)C(=O)O","inchiKey":"MUBZPKHOEPUJKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXALIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxalic Acid","Oxalic Acid Dianion"],"crossReferences":{"PubChem":["144209320","144213663"],"Wikipedia":["Oxalic_acid"],"drugbank":["DB03902"],"chEBI":["16995"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL155625","canonicalSmiles":"OCc1c[nH]c2ccccc12","inchiKey":"IVYPNXXAYMYVSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE-3-CARBINOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole 3-carbinol","Indole-3-carbinol","NSC-525801"],"crossReferences":{"PubChem":["124889851","144214016","17388972","26747235","57260065"],"Wikipedia":["Indole-3-carbinol"],"drugbank":["DB12881"],"chEBI":["24814"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL15891","canonicalSmiles":"Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl","inchiKey":"JLYXXMFPNIAWKQ-GNIYUCBRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LINDANE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esoderm","Gamene","Gamma Benzene HCl","Gexane","Kwell","Lindane","Lorexane","Lorexane no 3","Quellada","Scabene"],"synonyms":["Benzene hexachloride gamma","Benzene hexachloride, gamma","Gamma benzene hexachloride","Gammahexachlorcyclohexane","Gammallin","Gammaxene","Hexachlorane","Hexicide","Lindane","Lindanum","NSC-755895","gamma-Hexachlorocyclohexane"],"crossReferences":{"DailyMed":["lindane"],"PubChem":["144209267","144211270","26757360"],"Wikipedia":["Lindane"],"drugbank":["DB00431"],"chEBI":["32888"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for parasitic infection and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1618378","canonicalSmiles":"CCN(CC)CCNC(=O)c1ccc(N)c(Cl)c1","inchiKey":"YEYAKZXEBSVURO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECLOPRAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Declopramide"],"crossReferences":{"drugbank":["DB06421"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL16264","canonicalSmiles":"CCOCC","inchiKey":"RTZKZFJDLAIYFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anaesthetic ether","Diethyl ether","Ether","Ether anaesthesicus","Etherum","Ethyl ether","Ethyl oxide","NSC-100036","Pronarcol","Solvent ether"],"crossReferences":{"Wikipedia":["Diethyl_ether"],"drugbank":["DB13598"],"chEBI":["35702"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1651908","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2CC[C@]3(OC)[C@H]4CC[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)O[C@H](C)[C@H]1O","inchiKey":"UWRLEUQPRUZEBA-NECIELHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYMARIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cymarin","Cymarine","K-strophanthin-.alpha.","K-strophanthin-alpha","NSC-7522"],"crossReferences":{"Wikipedia":["Cymarin"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1653","canonicalSmiles":"CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SSOXZAQUVINQSA-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIRAMINE MALEATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1193","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avil ret","Daneral-sa"],"synonyms":["Antolozine","Daneral","Fervex","Inhiston","NSC-757270","Naphcon a","PM-241","Pheniramine Maleate","Pheniramine hydrogen maleate","Pheniramine maleate","Prophenpyridamine maleate","Trimeton","Trimetose"],"crossReferences":{"DailyMed":["pheniramine%20maleate"],"PubChem":["144204739","144208272","170464902","26747641","50106867","56422488","93576675"],"chEBI":["31990"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0007328","EFO_0007141","EFO_0007214","MONDO_0024355"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 3 investigational indications."}
{"id":"CHEMBL166937","canonicalSmiles":"CN(CC(N)=O)C(=O)N(CCCl)N=O","inchiKey":"HYHJFNXFVPGMBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARCNU","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-[{[(2-Chloroethyl)(Nitroso)Amino]Carbonyl}(Methyl)Amino]Acetamide","NSC-364432","Sarcnu","Sarmustine"],"crossReferences":{"PubChem":["466405"],"drugbank":["DB11688"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL169","canonicalSmiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C","inchiKey":"WCGUUGGRBIKTOS-GPOJBZKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URSOLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Malol","Micromerol","NSC-167406","NSC-4060","Prunol","Ursolic acid","Urson"],"crossReferences":{"PubChem":["124882839","26725260","26754242","56463656"],"Wikipedia":["Ursolic_acid"],"drugbank":["DB15588"],"chEBI":["9908"]},"childChemblIds":["CHEMBL520029","CHEMBL1783814","CHEMBL1783810"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1709","canonicalSmiles":"CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl","inchiKey":"BLFQGGGGFNSJKA-XHXSRVRCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SERTRALINE HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL809","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aremis","Besitron","Lustral","Sertraline hydrochloride","Zoloft"],"synonyms":["CP-51,974-1","CP-51974-1","NSC-746308","NSC-758948","Sertraline (as hydrochloride)","Sertraline hcl","Sertraline hydrochloride"],"crossReferences":{"DailyMed":["sertraline%20hydrochloride"],"PubChem":["144204750","170465121","26719805","26753298","26753614","49681568"],"chEBI":["9124"]},"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","MONDO_0002050","EFO_0004262","MONDO_0002009","EFO_0003761","EFO_0003847","EFO_0001358","EFO_1001917","EFO_0004242","HP_0002315"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 6 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL171623","canonicalSmiles":"OCCCCO","inchiKey":"WERYXYBDKMZEQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,4-BUTANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,4-Butanediol","Butane-1,4-Diol"],"crossReferences":{"PubChem":["144209443","144213357","49816801"],"Wikipedia":["1,4-Butanediol"],"drugbank":["DB01955"],"chEBI":["41189"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742420","canonicalSmiles":"CCOC(=O)NC(=N)c1ccc(OCc2cccc(COc3ccc(C(C)(C)c4ccc(O)cc4)cc3)c2)cc1","inchiKey":"SBVYURPQULDJTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMELUBANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amelubant","BIIL 284","BIIL 284 BS","BIIL-284","BIIL-284BS","Biil 284 bs","LS-49968"],"crossReferences":{"drugbank":["DB06248"]},"linkedTargets":{"rows":["ENSG00000213903"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","Orphanet_586","MONDO_0004979","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743025","drugType":"Antibody","blackBoxWarning":false,"name":"GANTENERUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gantenerumab","R-04909832","R-1450","R04909832","R1450","RG-1450","RO-4909832 R-1450","Ro-4909832"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL175367","canonicalSmiles":"Cc1nc2c(=O)[nH]c(N)nc2o1","inchiKey":"NEKSCFHMQPOHBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL175367","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1765292","canonicalSmiles":"CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1","inchiKey":"AYDXAULLCROVIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOBUFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibustrin","Indobufen","K-2930","K-3920"],"crossReferences":{"PubChem":["170466270"],"Wikipedia":["Indobufen"],"drugbank":["DB12545"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL192966","canonicalSmiles":"COC(=O)/C=C/c1cccc(N(Cc2ccc(-c3ccc(N(C)C)cc3)cc2)C(=O)C2CCCCC2)c1","inchiKey":"VLQTUNDJHLEFEQ-KGENOOAVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEXARAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexaramine"],"crossReferences":{"PubChem":["50112913"],"drugbank":["DB02545"],"chEBI":["80003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950576","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O","inchiKey":"ASXBYYWOLISCLQ-HZYVHMACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROSTREPTOMYCIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1970},"tradeNames":[],"synonyms":["Abiocine","Dihydrostreptomycin","Streptomycin, dihydro-","Vibriomycin"],"crossReferences":{"Wikipedia":["Dihydrostreptomycin"],"drugbank":["DB11512"],"chEBI":["38291"]},"childChemblIds":["CHEMBL3188576"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for eye infection. It was withdrawn in United States  in 1970 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL1951071","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"FCSXYHUNDAXDRH-QVRIGTRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARFORMOTEROL TARTRATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1363","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brovana"],"synonyms":["Arformoterol tartrate","Formoterol r,r-form l-tartrate"],"crossReferences":{"DailyMed":["arformoterol%20tartrate"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000464","EFO_0006505","EFO_0009661","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL20","canonicalSmiles":"CC(=O)Nc1nnc(S(N)(=O)=O)s1","inchiKey":"BZKPWHYZMXOIDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETAZOLAMIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetazolamide","Diamox","Diamox sr","Eytazox"],"synonyms":["Acetamox","Acetazolamide","Acetazolamidum","Atenezo","Defiltran","Didoc","Diuriwas","Donmox","Edemox","Glaupax","L 579486","NSC-145177","Nephramide","Phonurit"],"crossReferences":{"DailyMed":["acetazolamide"],"PubChem":["11110757","144208757","144213090","170464692","26747033","26751551","50104152","855900"],"TG-GATEs":["108"],"Wikipedia":["Acetazolamide"],"drugbank":["DB00819"],"chEBI":["27690"]},"childChemblIds":["CHEMBL1200814","CHEMBL542496"],"linkedTargets":{"rows":["ENSG00000167434","ENSG00000133742","ENSG00000104267","ENSG00000074410"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0003005","EFO_0001361","EFO_0003086","MONDO_0001744","EFO_0009373","EFO_0005252","EFO_0000373","EFO_0000474","EFO_0009444","EFO_0003144","EFO_1001065","EFO_0000712","EFO_0000182","EFO_0007231","EFO_1001132","EFO_1000961","EFO_0005804","EFO_0003877","HP_0002104","EFO_1001010","EFO_0008526","HP_0012532","Orphanet_79318","EFO_1000782","HP_0001250","Orphanet_37553","EFO_1002002","MONDO_0005499","MONDO_0005301","EFO_0000702","EFO_0000341","EFO_0000516","EFO_0003918","EFO_0011056"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 8 approved and 19 investigational indications."}
{"id":"CHEMBL2010507","canonicalSmiles":"CNC(C)Cc1ccccc1OC","inchiKey":"OEHAYUOVELTAPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXYPHENAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methoxyphenamine"],"crossReferences":{"PubChem":["144206596","170465530"],"drugbank":["DB13624"]},"childChemblIds":["CHEMBL1985928"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL2062263","canonicalSmiles":"NCCS.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NSKJTUFFDRENDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEAMINE BITARTRATE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL602","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cystagon","Procysbi"],"synonyms":["Cysteamine bitartrate","Mercamine bitartrate","Mercaptamine bitartrate","RP-103"],"crossReferences":{"DailyMed":["cysteamine%20bitartrate"],"chEBI":["50386"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for cystinosis and has 3 investigational indications."}
{"id":"CHEMBL2103846","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"HKDLNTKNLJPAIY-WKWWZUSTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIPRISTAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Uliprisnil","Ulipristal","Ulipristal acetate ulipristal"],"crossReferences":{"drugbank":["DB08867"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000731","EFO_0001065","MONDO_0003061","MONDO_0001572"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104027","canonicalSmiles":"CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@@H]1CC","inchiKey":"ODEGQXRCQDVXSJ-WMLDXEAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHAMEPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACSCN-9608","Alphameprodine","IDS-NA-009","Meprodine"],"crossReferences":{"drugbank":["DB01499"]},"childChemblIds":["CHEMBL3244453"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104793","canonicalSmiles":"CCCC(C(=O)c1ccc(C)cc1)N1CCCC1.Cl","inchiKey":"MWRACNBZNVAJHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROVALERONE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL201960","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Misuse"],"year":1979},"tradeNames":[],"synonyms":["Centroton","F 1983","F-1983","Pyrovalerone hcl","Pyrovalerone hydrochloride","SP-1059","Thymergix"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1979 due to Misuse."}
{"id":"CHEMBL2105167","canonicalSmiles":"COc1ccc2c(c1)C(O)(CCCN(C)C)c1ccccc1S2","inchiKey":"LAYVFLWAVIGDLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPROTIXOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meprothixol","Meprotixol","N-7020"],"crossReferences":{"drugbank":["DB13822"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105233","canonicalSmiles":"C=CCC1(CC(C)O)C(=O)NC(=O)NC1=O","inchiKey":"VNLMRPAWAMPLNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROXIBARBAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," France"," Italy"," Portugal"," Turkey"],"classes":["Hematological toxicity"," Immune system toxicity"],"year":1998},"tradeNames":[],"synonyms":["Axeen","Centralgol","HH-184","Hydroxydial","Ipronal","Proxibarbal"],"crossReferences":{"drugbank":["DB13253"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Spain,  France,  Italy,  Portugal and  Turkey initially in 1998 due to Hematological toxicity and  Immune system toxicity."}
{"id":"CHEMBL2105394","canonicalSmiles":"CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC)CC[C@@H]12","inchiKey":"IUWKNLFTJBHTSD-AANPDWTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMESTRIENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Colpotrophine","Promestriene"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105666","canonicalSmiles":"CCc1c2c(nc3ccc(OC(=O)CCC(=O)Oc4c(C)c(C)c5c(c4C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O5)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC","inchiKey":"KRHZRBUSQSYTTP-PTXGIJCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENIFATECAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SN-2310","SN2310","Tenifatecan"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2105729","canonicalSmiles":"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O","inchiKey":"YKGMKSIHIVVYKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABRAFENIB MESYLATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2028663","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tafinlar"],"synonyms":["Dabrafenib mesilate","Dabrafenib mesylate","GSK-2118436 METHANESULFONATE SALT","GSK-2118436B","GSK-2118436B MESYLATE","GSK-2118436B METHANESULFONATE SALT","GSK2118436B","GSK2118436B, METHANE SULFONATE SALT","METHANE SULFONATE SALT"],"crossReferences":{"DailyMed":["dabrafenib%20mesylate"],"chEBI":["75048"]},"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0002892","EFO_0000389","MONDO_0002108","EFO_0000756","EFO_1000926","EFO_0001378","EFO_0002617"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 5 approved and 2 investigational indications."}
{"id":"CHEMBL2107827","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl","inchiKey":"NGKHWQPYPXRQTM-UKFSEGPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDOXORUBICIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2107818","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Inno-206"],"synonyms":["Aldoxorubicin hydrochloride","INNO-206 HYDROCHLORIDE"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2107860","drugType":"Protein","blackBoxWarning":false,"name":"TASPOGLUTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIM-51077","BIM51077","R-1583","R1583","RO-5073031","RO5073031","Taspoglutide"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108162","drugType":"Antibody","blackBoxWarning":false,"name":"TUVIRUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ostavir"],"synonyms":["OST-577","Ostavir human anti-hepatitis b","PE 1-1","PE-1-1","PE1-1","SDZ OST 577","SDZ-OST 577","SDZ-OST-577","Tuvirumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108402","drugType":"Enzyme","blackBoxWarning":false,"name":"EPAFIPASE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epafipase","RPAF-AH"],"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108405","drugType":"Unknown","blackBoxWarning":false,"name":"EPTACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eptacog alfa","Eptacog alfa (activated)","Eptacog beta (activated)","LR-769","LR769"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108876","drugType":"Unknown","blackBoxWarning":false,"name":"TETANUS TOXOID ADSORBED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetanus toxoid adsorbed"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109059","drugType":"Protein","blackBoxWarning":false,"name":"EDODEKIN ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edodekin alfa","Human il-12 (recombinant)","Interleukin 12 (human)","Interleukin-12, human","RO 24-7472","RO 24-7472/000","RO-24-7472","RO-247472000","Recombinant interleukin-12"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 57 investigational indications."}
{"id":"CHEMBL2109562","drugType":"Antibody","blackBoxWarning":false,"name":"CAL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAL","Cal"],"linkedTargets":{"rows":["ENSG00000087494"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","MONDO_0007254"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2151197","canonicalSmiles":"CCNC(=O)[C@H]1C[C@@](F)(c2ccc(CN3CCCC3)c(F)c2)C1","inchiKey":"SXMBKHYDZOCBMT-PPUGGXLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03654746","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF 03654746","Pf-03654746"],"crossReferences":{"drugbank":["DB12201"]},"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0003888","MONDO_0005090","EFO_0004895","MONDO_0004975"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2219776","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CENERSEN SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenersen sodium","EL-625","EL625","OL(1)P53"],"linkedTargets":{"rows":["ENSG00000141510"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL223533","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"PCDQPRRSZKQHHS-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTETINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cystetine Triphosphate"],"crossReferences":{"drugbank":["DB02431"],"chEBI":["17677"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230347","canonicalSmiles":"N#Cc1cnn2c(Nc3ccccc3)nc(NCc3ccc(Cl)cc3)nc12","inchiKey":"QCVULERVJOYHCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08354"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL25202","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21","inchiKey":"MUTNCGKQJGXKEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAMIBAROTENE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-80","Am80","Amnoid","INNO-507","NSC-608000","OP-01","RR-110","SY-1425","Sy-1425","TM-411","TOS-80T","Tamibarotene"],"crossReferences":{"PubChem":["144206278","170465883","485050","50125822"],"Wikipedia":["Tamibarotene"],"drugbank":["DB04942"],"chEBI":["32181"]},"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002618","EFO_0005761","MONDO_0004975","EFO_0000222","EFO_0007527","EFO_0000224","EFO_0000384"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL25826","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"GGPXNASQNUOIPB-NSOVKSMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARATOULENE PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paratoulene Phosphate"],"crossReferences":{"drugbank":["DB04495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286364","canonicalSmiles":"CC(C)C[C@H](NC(=O)c1cc2ccccc2o1)C(=O)N[C@H]1CCCN(S(=O)(=O)c2ccccn2)CC1=O","inchiKey":"VBPPNJCVXGAZDD-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286364","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297792","canonicalSmiles":"Cc1ccc(C#Cc2ccc(S(=O)(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)O)s2)cc1","inchiKey":"YWCLDDLVLSQGSZ-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-3304","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S 3304","S-3304"],"crossReferences":{"drugbank":["DB12149"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL30713","canonicalSmiles":"CC(N)Cc1c[nH]c2ccccc12","inchiKey":"QSQQQURBVYWZKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"alpha-Methyltryptamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["alpha-Methyltryptamine"],"crossReferences":{"Wikipedia":["Alpha-Methyltryptamine"],"drugbank":["DB01446"],"chEBI":["59020"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL313405","canonicalSmiles":"N#Cc1ccc(Nc2nc(N)nc(Cc3c(Cl)ccc4[nH]ccc34)n2)cc1","inchiKey":"SOKOHDQTKSROQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-120393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-120393"],"crossReferences":{"drugbank":["DB07337"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183193","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1.Cl","inchiKey":"MPTNDTIREFCQLK-UNVJPQNDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMENOXIME HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201224","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefmax","Tacef"],"synonyms":["ABBOTT-50192","ABBOTT-50192 (HCL)","Cefmenoxime hcl","Cefmenoxime hydrochloride","NSC-760352","SCE-1365 (TAKEDA) (BASE)"],"crossReferences":{"PubChem":["144206020"],"chEBI":["31370"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL3188386","canonicalSmiles":"Cc1cc(-c2ncc(CC(=O)Nc3ccc(-c4cnccn4)cn3)cc2C)ccn1","inchiKey":"XXYGTCZJJLTAGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WNT-974","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGK-974","LGK974","Lgk974","WNT-974","WNT974","Wnt-974","Wnt974"],"crossReferences":{"PubChem":["174006720"],"drugbank":["DB12561"],"chEBI":["78030"]},"linkedTargets":{"rows":["ENSG00000102312"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0000707"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL35107","canonicalSmiles":"CC(C)C[C@H](O)[C@H](O)[C@@H](N)CC1CCCCC1","inchiKey":"KGYZGGUJJIVOQX-MELADBBJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL35107","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08740"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545338","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-0259","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GLPG-0259","GLPG0259","Glpg-0259"],"linkedTargets":{"rows":["ENSG00000089022"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545407","canonicalSmiles":"O=[N+]([O-])OC[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"AQLVRTWKJDTWQQ-SDBHATRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRABODENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INNO-8875","Ino-8875","PJ-875","Trabodenoson"],"crossReferences":{"drugbank":["DB13122"]},"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL354541","canonicalSmiles":"O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1","inchiKey":"MBBCVAKAJPKAKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOMITAPIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lojuxta"],"synonyms":["AEGR-733","BMS-201038","BMS-201038-01","Lomitapide"],"crossReferences":{"DailyMed":["lomitapide%20mesylate"],"drugbank":["DB08827"],"chEBI":["72297"]},"childChemblIds":["CHEMBL2105662"],"linkedTargets":{"rows":["ENSG00000138823"],"count":1},"linkedDiseases":{"rows":["HP_0003124","MONDO_0021187","Orphanet_391665","EFO_0000319","EFO_0004911"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 4 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3561076","canonicalSmiles":"COc1ccc(CN2CCNCC2)c(OC)c1OC.Cl.Cl","inchiKey":"VYFLPFGUVGMBEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETAZIDINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL203266","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-759317","Trimetazidine di-hcl","Trimetazidine dihydrochloride","Trimetazidine hcl","Trimetazidine hydrochloride","Trimethazidine dihydrochloride"],"crossReferences":{"PubChem":["170465797"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3674570","canonicalSmiles":"CC1(C)CC=C(c2nc(C3CC(C)(C)OC(C)(C)C3)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1","inchiKey":"BNVPFDRNGHMRJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDICOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edicotinib","JNJ-40346527","Jnj-40346527"],"crossReferences":{"drugbank":["DB12504"]},"childChemblIds":["CHEMBL4297225"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000673","EFO_0000222"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707227","drugType":"Antibody","blackBoxWarning":false,"name":"ATEZOLIZUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tecentriq"],"synonyms":["0ine2sfd9e","Anti-PD-L1","Anti-PDL1","Atezolizumab","MPDL-3280A","MPDL3280A","RG-7446","RG7446"],"crossReferences":{"DailyMed":["atezolizumab"],"DrugCentral":["5151"]},"linkedTargets":{"rows":["ENSG00000120217"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0000637","EFO_0001075","EFO_0000756","EFO_0000681","EFO_1000657","EFO_0005952","EFO_1001951","EFO_0000339","EFO_0000096","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_1000251","EFO_0008528","EFO_1000532","EFO_1000785","EFO_0000198","EFO_0002618","EFO_0005922","EFO_0003893","EFO_1001956","MONDO_0008170","EFO_0003017","EFO_1001973","EFO_1001512","MONDO_0004986","MONDO_0044881","MONDO_0044791","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_0007143","EFO_0009708","EFO_1000489","EFO_0005567","EFO_0001061","EFO_1001100","EFO_0005537","EFO_0008524","EFO_0004284","EFO_0000574","EFO_1001051","EFO_0001378","EFO_0006544","EFO_1000613","MONDO_0100342","MONDO_0015686","EFO_1001465","MONDO_0007254","EFO_0000305","EFO_1001513","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","MONDO_0002158","EFO_0000770","MONDO_0002898","EFO_0000673","EFO_0000196","EFO_0000183","MONDO_0002083","EFO_0002617","EFO_0000616","EFO_0000186","MONDO_0021058","EFO_0006859","EFO_0002916","EFO_0000503","EFO_0000403","Orphanet_44890","MONDO_0007576","EFO_0000222","EFO_0000313","EFO_1000088","EFO_0003060","EFO_1000124","EFO_0000311","EFO_1001961","EFO_0003863","EFO_0000304","MONDO_0002529","EFO_0000095","EFO_0002892","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_0004142","MONDO_0002367","MONDO_0003219","MONDO_0018906","MONDO_0024880","EFO_1001927","EFO_0000519","EFO_0000181","EFO_0000691"],"count":100},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 7 approved and 65 investigational indications."}
{"id":"CHEMBL373204","canonicalSmiles":"CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1","inchiKey":"KAATUXNTWXVJKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHA-CYPERMETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-cypermethrin",".zeta.-cypermethrin","Alpha-Cypermethrin","Alpha-cypermethrin","Alphacypermethrin","Cypermethrin","Cypermethrin, .zeta.-","Dudu alpha","NSC-760420","WL85871"],"crossReferences":{"PubChem":["124892259","144207128","144211209","170466657","26754615","26754616","26756819"],"Wikipedia":["Cypermethrin"],"drugbank":["DB13721"],"chEBI":["4042"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL387385","canonicalSmiles":"O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1","inchiKey":"YMUYGRBBEDYUOP-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL387385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07264"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL401843","canonicalSmiles":"Cc1cccc2c(=O)[nH]c(CCCN3CC=C(c4ccc(F)cc4)CC3)nc12","inchiKey":"LOFDUAJQRUYHBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401843","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL407567","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)C[N+](=O)[O-]","inchiKey":"GCXOTBPCUQHSAO-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL407567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL418052","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O","inchiKey":"ZJUKTBDSGOFHSH-WFMPWKQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-ADENOSYLHOMOCYSTEINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-Adenosyl Homocysteine","S-Adenosyl-Homocysteine","S-Adenosylhomocysteine"],"crossReferences":{"Wikipedia":["S-Adenosyl-L-homocysteine"],"drugbank":["DB01752"],"chEBI":["16680"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297320","canonicalSmiles":"CCCCCCC(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N2C[C@H](C(N)=O)NC(=O)[C@@H]2CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCCC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O","inchiKey":"HSHVZRILAMZYHY-WXSGKXQHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PL-3994","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pl-3994"],"linkedTargets":{"rows":["ENSG00000169418"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","MONDO_0004979"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297349","canonicalSmiles":"C[C@@H]1NC(=O)[C@H](CC(=O)O)NC1=O","inchiKey":"RVLCUCVJZVRNDC-IMJSIDKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARTYL-ALANYL-DIKETOPIPERAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampion","Aspartyl-alanyl-diketopiperazine","Da-dkp"],"crossReferences":{"drugbank":["DB14940"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297362","canonicalSmiles":"N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CC1CCCCC1)NC(=O)[C@@H](Cc1c(F)c(F)c(F)c(F)c1F)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1ccc(C(=O)c2ccccc2)cc1)C(=O)O","inchiKey":"DEZJGRPRBZSAKI-KMGSDFBDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CBP-501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBP501","Cbp 501","Cbp-501","Cbp501"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297401","canonicalSmiles":"Cc1ccc(N2CCNCC2)c(S(=O)(=O)O)c1.O","inchiKey":"ZRQKZWAOIRVBFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALDARET MONOHYDRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2106572","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caldaret monohydrate","Mcc-135"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297527","canonicalSmiles":"O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12","inchiKey":"IXQHNBONEVULTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVAMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Revamilast"],"crossReferences":{"drugbank":["DB11838"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297600","canonicalSmiles":"NC(=O)c1ccn(-c2cnc(NC[C@]3(c4ncccc4F)C[C@H](F)C3)nc2)c1","inchiKey":"MQXWPWOCXGARRK-HJGJAMNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELDESEMTIV","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-2127107","Ck-2127107","Reldesemtiv"],"crossReferences":{"drugbank":["DB15256"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297704","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986012","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986012","Bms-986012"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297843","drugType":"Antibody","blackBoxWarning":false,"name":"TORIPALIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-pd-i mab-shanghai junshi","JS-001","JS001","Js-001","Js001","TAB-001","TAB001","Toripalimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003891","EFO_1001972","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_0004252","EFO_0002890","EFO_1001951","MONDO_0001187","EFO_0003826","MONDO_0001056","EFO_1001480","MONDO_0021358","EFO_0000178","EFO_1000044","EFO_0000769","MONDO_0002974","EFO_0000770","MONDO_0008903","EFO_0000182","EFO_0008528","MONDO_0004116","EFO_0000707","EFO_0002617","EFO_0004288","EFO_0001416","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0005922","EFO_0000503","MONDO_0002108","MONDO_0007576","EFO_1001968","EFO_0003060","EFO_0005221","EFO_0000311","EFO_1001961","MONDO_0000544","MONDO_0002120","EFO_0003868","MONDO_0000831","EFO_0005537","MONDO_0019472","EFO_0000702","EFO_0000574","EFO_0000199","EFO_0006544","MONDO_0018079","EFO_1000600","EFO_0000691","EFO_0000181","EFO_0000569"],"count":54},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 42 investigational indications."}
{"id":"CHEMBL4297845","drugType":"Unknown","blackBoxWarning":false,"name":"TRU-015","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-5212374","Tru-015"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690","EFO_0000574"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298002","drugType":"Antibody","blackBoxWarning":false,"name":"ICHORCUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ichorcumab","JNJ-64179375","JNJ-9375","Jnj-64179375"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4298060","drugType":"Unknown","blackBoxWarning":false,"name":"SOY ISOFLAVONES","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Novasoy","Solgen 40","Soy germ isoflavones","Soy isoflavones","Soya isoflavones","Soybean isoflavones","Soybean isoflavoues"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298113","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"BAMOSIRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamosiran","SYL-040012","SYL040012","Syl040012"],"description":"Oligonucleotide drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL44228","canonicalSmiles":"Clc1cc(Cl)cc(Cl)c1","inchiKey":"XKEFYDZQGKAQCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,3,5-TRICHLOROBENZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3,5-Trichloro-Benzene","1,3,5-Trichlorobenzene"],"crossReferences":{"PubChem":["144207477","17389471"],"Wikipedia":["1,3,5-Trichlorobenzene"],"drugbank":["DB03836"],"chEBI":["49916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594364","drugType":"Unknown","blackBoxWarning":false,"name":"FPT-155","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd80-fc fusion protein fpt155","Fpt-155","Fpt155"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL465026","canonicalSmiles":"CN1CCOC(c2ccccc2)c2ccccc2C1","inchiKey":"RGPDEAGGEXEMMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEFOPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nefopam"],"crossReferences":{"PubChem":["26748505"],"drugbank":["DB12293"],"chEBI":["88318"]},"childChemblIds":["CHEMBL1407915"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever and has 2 investigational indications."}
{"id":"CHEMBL4650526","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ROVANERSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMTR-5150","BMTR5150","Rovanersen","WV-1092","WVE-120101","Wve-120101"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL472565","canonicalSmiles":"Cc1c(C(N)=O)cc([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"ZEFNOZRLAWVAQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINITOLMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5-dinitro-o-toluamide","D.o.t.","Dinitolmide","Dinitrotoluamide","Methyldinitrobenzamide","NSC-758213","Zoalele","Zoalene","Zoamix"],"crossReferences":{"PubChem":["144204927","170465727","89854490"],"Wikipedia":["Zoalene"],"drugbank":["DB11480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802223","canonicalSmiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1.CS(=O)(=O)O","inchiKey":"MBIDSOMXPLCOHS-XNHQSDQCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LEUPROLIDE MESYLATE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201199","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camcevi kit"],"synonyms":["Camcevi","Leuprolide mesylate","Leuprorelin mesilate","Leuprorelin mesylate"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for prostate cancer."}
{"id":"CHEMBL505147","canonicalSmiles":"CSc1ccc(Oc2ccc(S(N)(=O)=O)cc2CN(C)C)cc1","inchiKey":"VCNSPGHSQPMCFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UK-390957","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UK-390,957","Uk-390,957","Uk-390957"],"crossReferences":{"drugbank":["DB11719"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL53366","canonicalSmiles":"Cc1nccn1CCC(C(N)=O)(c1ccccc1)c1ccccc1","inchiKey":"SQKXYSGRELMAAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIDAFENACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imidafenacin","KRP-197","ONO-8025","Staybla","Uritos"],"crossReferences":{"drugbank":["DB09262"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL53463","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"AOJJSUZBOXZQNB-TZSSRYMLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXORUBICIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adriblastina"],"synonyms":["Adriablastin","Adriamycin","Doxil","Doxorubicin","Epirubicin hydrochloride impurity, doxorubicin-","Hydroxydaunorubicin","NSC-123127","NSC-759155","Rubex","Valrubicin impurity, doxorubicin"],"crossReferences":{"DailyMed":["doxorubicin%20hydrochloride"],"PubChem":["124886887","124886893","164339434"],"TG-GATEs":["149"],"Wikipedia":["Doxorubicin"],"drugbank":["DB00997"],"chEBI":["28748"]},"childChemblIds":["CHEMBL359744","CHEMBL272706","CHEMBL216371"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000637","EFO_0004708","EFO_0011061","EFO_0000558","EFO_0003859","EFO_0000681","EFO_1000231","MONDO_0002730","EFO_0005952","EFO_1000984","EFO_0000632","EFO_1001951","EFO_1001952","MONDO_0015760","EFO_1001935","EFO_0000588","EFO_0000096","EFO_0000564","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0002918","EFO_0000760","MONDO_0021054","EFO_0000198","EFO_0002618","EFO_1001968","EFO_1001946","MONDO_0004986","MONDO_0008315","EFO_0005221","MONDO_0002691","Orphanet_398934","EFO_0000630","EFO_1001365","MONDO_0044889","EFO_0003032","EFO_0009254","EFO_1000527","MONDO_0019472","EFO_0000574","EFO_0001378","EFO_1000796","MONDO_0015564","EFO_0001376","MONDO_0002928","MONDO_0003175","MONDO_0021117","EFO_0002913","MONDO_0007254","EFO_0000255","Orphanet_790","EFO_0004252","MONDO_0004095","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0003968","EFO_1001974","MONDO_0017387","EFO_0004289","MONDO_0012825","EFO_0002499","EFO_0000183","EFO_0004193","MONDO_0002083","MONDO_0002618","EFO_0000616","EFO_0006859","EFO_0000765","EFO_1000314","EFO_0000403","EFO_1001042","EFO_0000222","MONDO_0000870","MONDO_0007576","EFO_1001953","EFO_0000304","EFO_0002517","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0019004","MONDO_0024880","EFO_0000519","MONDO_0000873","EFO_0003869","EFO_0001075","EFO_1000131","EFO_0005561","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0002612","HP_0001871","MONDO_0019460","EFO_0000389","EFO_0000182","MONDO_0019088","MONDO_0018531","MONDO_0015540","EFO_0000094","Orphanet_654","Orphanet_145","EFO_1000595","EFO_0003893","MONDO_0004658","EFO_1000292","EFO_0000220","MONDO_0002108","EFO_0000248","MONDO_0008170","MONDO_0005094","MONDO_0004669","EFO_0000223","EFO_0000502","MONDO_0044881","EFO_0009708","EFO_0007143","EFO_1000576","EFO_1001100","EFO_1000238","EFO_0005537","MONDO_0044917","EFO_0000432","EFO_0006544","Orphanet_314701","EFO_0000569","MONDO_0009348","MONDO_0000432","MONDO_0019471","MONDO_0100342","MONDO_0015686","MONDO_0004192","EFO_1001901","EFO_0004230","EFO_1001469","EFO_0000209","MONDO_0002087","EFO_0000305","EFO_0003085","EFO_0000231","MONDO_0001187","MONDO_0016691","EFO_1001480","EFO_1000044","MONDO_0001475","EFO_0000770","Orphanet_31112","HP_0002017","MONDO_0001657","EFO_0003144","EFO_0000673","MONDO_0020743","EFO_0010580","EFO_0000239","EFO_0002617","EFO_1000158","EFO_0002914","MONDO_0000430","EFO_0000437","EFO_0000503","MONDO_0002678","EFO_1000350","EFO_0000313","MONDO_0016717","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000211","EFO_1000581","EFO_0006861","EFO_0000095","EFO_0006475","EFO_0000174","MONDO_0002621","EFO_1001936","MONDO_0020077","EFO_0000691"],"count":183},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 23 approved and 164 investigational indications."}
{"id":"CHEMBL537","canonicalSmiles":"Oc1ccc(O)cc1","inchiKey":"QIGBRXMKCJKVMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROQUINONE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Black and white bleaching cream","Eldopaque forte","Eldoquin forte","Solaquin forte"],"synonyms":["CHEBI:17594","CHEMBL537","Hydroquinone","NCI-C55834","NSC-9247"],"crossReferences":{"DailyMed":["hydroquinone"],"PubChem":["104171174","11111286","124880354","144203720","144209543","144210335","170464661","17389853","26747267","46500618","50105477","85231080","90340863"],"Wikipedia":["Hydroquinone"],"drugbank":["DB09526"],"chEBI":["17594"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for lentigo and freckles."}
{"id":"CHEMBL551978","canonicalSmiles":"CCOc1ccc(/C=C2\\NCCc3cc(OCC)c(OCC)cc32)cc1OCC","inchiKey":"OMFNSKIUKYOYRG-MOSHPQCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DROTAVERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroethaverine","Dihydroisoperparine","Drotaverin","Drotaverine","Drotin"],"crossReferences":{"Wikipedia":["Drotaverine"],"drugbank":["DB06751"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0010282","HP_0100607"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL558","canonicalSmiles":"Cc1cccc(C)c1OCC(C)N","inchiKey":"VLPIATFUUWWMKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEXILETINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(rs)-mexiletine","Dl-mexiletine","Mexiletine"],"crossReferences":{"DailyMed":["mexiletine%20hydrochloride"],"PubChem":["90341048"],"TG-GATEs":["103"],"Wikipedia":["Mexiletine"],"drugbank":["DB00379"],"chEBI":["6916"]},"childChemblIds":["CHEMBL1200606"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["HP_0012532","EFO_0004269","Orphanet_93955","EFO_0000555","EFO_0004278","EFO_0009387","Orphanet_206656","HP_0003394","Orphanet_166","EFO_0009562","Orphanet_206647","EFO_0004287","HP_0004308","EFO_0000612","Orphanet_273","MONDO_0004976","EFO_0001357"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for cardiac arrhythmia and ventricular arrhythmia and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL559973","canonicalSmiles":"N[C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)O","inchiKey":"INPQIVHQSQUEAJ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROTRYPTOPHANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL59990","canonicalSmiles":"O=P1(N(CCCl)CCCl)NC(SCCS(=O)(=O)O)CCO1","inchiKey":"PBUUPFTVAPUWDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFOSFAMIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mafosfamide"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL607023","canonicalSmiles":"CC1(C)CC(O)CC(C)(C)N1[O]","inchiKey":"UZFMOKQJFYMBGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMPOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-oxypiperidol","MBM-02","NSC-142784","SPJ-701","Tanol","Tempol","ZJ-701"],"crossReferences":{"PubChem":["144211189","174006259"],"Wikipedia":["4-Hydroxy-TEMPO"],"drugbank":["DB12449"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL636","canonicalSmiles":"CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1","inchiKey":"XSVMFMHYUFZWBK-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVASTIGMINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alzest","Eluden","Erastig","Exelon","Kerstipon","Nimvastid","Prometax","Rivastigmine","Somniton","Voleze"],"synonyms":["ENA-713","ENA-713D","ONO-2540","Rivastigmine","Rivastigmine hexal","Rivastigmine sandoz","Rivastigmine teva","SDZ-212-713","SDZ-212713","SDZ-ENA-713"],"crossReferences":{"DailyMed":["rivastigmine","rivastigmine%20tartrate"],"Wikipedia":["Rivastigmine"],"drugbank":["DB00989"],"chEBI":["8874"]},"childChemblIds":["CHEMBL215645","CHEMBL1201092","CHEMBL3187096"],"linkedTargets":{"rows":["ENSG00000087085","ENSG00000114200"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0009386","EFO_0004718","HP_0000726","EFO_0005252","EFO_0009267","HP_0100543","EFO_0003890","MONDO_0002491","MONDO_0002050","Orphanet_683","MONDO_0005180","EFO_0000764","MONDO_0004975","EFO_0001064","EFO_0004701","MONDO_0043510","EFO_0004364","EFO_0005230"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 15 investigational indications."}
{"id":"CHEMBL747","canonicalSmiles":"CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1","inchiKey":"QMNFFXRFOJIOKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOGUANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cycloguanil","Malarone"],"crossReferences":{"Wikipedia":["Cycloguanil"],"drugbank":["DB14763"]},"childChemblIds":["CHEMBL3989825","CHEMBL588912","CHEMBL544227"],"description":"Small molecule drug with a maximum clinical trial phase of I and is indicated for malaria."}
{"id":"CHEMBL788","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I","inchiKey":"XQFRJNBWHJMXHO-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDOXURIDINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dendrid","Herplex","Idox","Kerecid","Ophthalmadine","Stoxil"],"synonyms":["5-IUDR","5IUDR","ALLERGAN 211","ALLERGAN-211","Allergan 211","Allergan-211","IDU","Idoxuridine","Idoxuridinum","Joddeoxiuridin","NSC-39661","SK&F 14287","SK&F-14287"],"crossReferences":{"PubChem":["144203875","170465014","56463655"],"Wikipedia":["Idoxuridine"],"drugbank":["DB00249"],"chEBI":["147675"]},"childChemblIds":["CHEMBL3967390"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for eye infection and viral disease and has 1 investigational indication."}
{"id":"CHEMBL792","canonicalSmiles":"Oc1nc(O)c2nc(O)[nH]c2n1","inchiKey":"LEHOTFFKMJEONL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,6,8-trioxypurine","Idelalisib metabolite m54","Lithic acid","NSC-3975","Uric acid","Uricum acidum"],"crossReferences":{"Wikipedia":["Uric_acid"],"drugbank":["DB08844"],"chEBI":["17775"]},"childChemblIds":["CHEMBL1951298","CHEMBL2079813"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL848","canonicalSmiles":"Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O","inchiKey":"GOTYRUGSSMKFNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LENALIDOMIDE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revlimid"],"synonyms":["CC-5013","CDC-501","Lenalidomide","NSC-747972","SYP-1512"],"crossReferences":{"DailyMed":["lenalidomide"],"PubChem":["124893327","124893328","144206045","170465201"],"Wikipedia":["Lenalidomide"],"drugbank":["DB00480"],"chEBI":["63791"]},"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["EFO_0004708","EFO_0000558","EFO_0000756","EFO_0000681","MONDO_0002959","EFO_1000657","EFO_0005952","EFO_0000540","Orphanet_85443","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0004251","MONDO_0015760","EFO_0000339","EFO_0000096","MONDO_0002280","HP_0001871","HP_0007141","EFO_0000182","EFO_0009441","EFO_0000198","EFO_0002618","MONDO_0013730","EFO_0000220","MONDO_0008170","EFO_0000180","EFO_0003758","EFO_1000157","MONDO_0017596","MONDO_0044881","EFO_0000384","EFO_0002429","MONDO_0008315","EFO_0009708","EFO_0000294","MONDO_0002691","EFO_1000026","MONDO_0044889","EFO_0003841","MONDO_0001023","MONDO_0100096","HP_0004326","EFO_0000574","EFO_0001378","Orphanet_314701","EFO_1001115","EFO_0003073","EFO_1001998","MONDO_0044903","MONDO_0019471","MONDO_0100342","MONDO_0004192","EFO_0002913","MONDO_0044887","EFO_1001465","EFO_1001469","EFO_0000209","MONDO_0004095","MONDO_0021063","MONDO_0003541","MONDO_0002087","MONDO_0001187","EFO_0002430","MONDO_0002158","EFO_0000769","EFO_1000630","EFO_0000196","EFO_0000673","EFO_0004272","EFO_0002499","EFO_0000183","EFO_0000707","MONDO_0002083","EFO_1000158","MONDO_0000430","EFO_0000479","EFO_0000616","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_0000621","EFO_0003060","MONDO_0006412","EFO_0006738","EFO_0000311","EFO_0000211","EFO_0003834","EFO_1001934","EFO_0000095","EFO_0006475","EFO_0002892","EFO_0000764","EFO_0002517","EFO_0004142","EFO_0000191","MONDO_0002367","MONDO_0018906","MONDO_0024880"],"count":100},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 6 approved and 80 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL88055","canonicalSmiles":"Oc1ccc(C(O)C2CCCCN2)cc1O","inchiKey":"IYMMESGOJVNCKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMITEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rimiterol"],"childChemblIds":["CHEMBL2000813"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL92567","canonicalSmiles":"CC(C)(C)OC(=O)N[C@H](C=O)C1CCCCC1","inchiKey":"BDSGOSWEKUGHOV-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92567","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04523"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
